Is Bayer's first sell-off here? Animal health may be up for grabs as Monsanto weighs on pharma
admin 11th October 2018 Uncategorised 0Bayer appears to be taking notes from investors and analysts calling for a split-up after its gigantic Monsanto buyout—and amid fears that its pharma business will suffer under its weight. The German company is reportedly considering hiving off its animal health unit as part of a broader portfolio review.
More: Is Bayer's first sell-off here? Animal health may be up for grabs as Monsanto weighs on pharma
Source: fierce